Abstract
A prospective double-blind, randomized, controlled clinical trial was conducted to assess the use of ADCON-T/N after flexor tendon repair in Zone II. Forty-five patients with 82 flexor tendon repairs in 50 digits completed the study. ADCON-T/N was injected into the tendon sheath after tenorrhaphy in the experimental group while the control group was not treated with ADCON-T/N. ADCON-T/N had no statistically significant effect on total active motion at 3,6 and 12 months but the time taken to achieve the final range of motion was significantly shorter in treated patients. ADCON-treated patients had a higher rupture rate but this was not significant.
Original language | English |
---|---|
Pages (from-to) | 113-115 |
Number of pages | 2 |
Journal | Journal of Hand Surgery (European Volume) |
Volume | 28 |
Issue number | 2 |
DOIs | |
Publication status | Published - Apr 2003 |